These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23350250)

  • 1. Seroprevalence study in Vojvodina (Serbia) following 2009 pandemic influenza A(H1N1)V.
    Petrović V; Reguljev Z; Nedeljković J; Ristić M
    Srp Arh Celok Lek; 2012; 140(11-12):751-5. PubMed ID: 23350250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.
    Maltezou HC; Katerelos P; Mavrouli M; Lourida A; Routsias JG; Spanakis N; Maragos A; Tedoma A; Bassiakos Y; Koratzanis G; Mantagos S; Metallidis S; Katragkou A; Nikolaidis P; Roilides E; Theodoridou M; Tsakris A
    Vaccine; 2011 Sep; 29(38):6664-9. PubMed ID: 21762749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.
    Poeppl W; Poeppl G; Hunger M; Tobudic S; Winkler H; Faas A; Mooseder G; Burgmann H
    J Med Virol; 2012 Sep; 84(9):1331-4. PubMed ID: 22825809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008-2010.
    Sam IC; Shaw R; Chan YF; Hooi PS; Hurt AC; Barr IG
    J Med Virol; 2013 Aug; 85(8):1420-5. PubMed ID: 23765779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.
    Tsai TF; Pedotti P; Hilbert A; Lindert K; Hohenboken M; Borkowski A; Groth N; da Silva LJ; Kyaw MH
    Euro Surveill; 2010 Jul; 15(30):. PubMed ID: 20684814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran.
    Moghadami M; Moattari A; Tabatabaee HR; Mirahmadizadeh A; Rezaianzadeh A; Hasanzadeh J; Ebrahimi M; Zamiri N; Alborzi A; Bagheri Lankarani K
    Iran J Immunol; 2010 Mar; 7(1):39-48. PubMed ID: 20371918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological features of 2009 pandemic H1N1 influenza differ slightly according to seroprevalence status during the second wave in the general population in México.
    Elizondo-Montemayor L; Hernández-Torre M; Ugalde-Casas PA; Santos-Guzmán J; Serrano-González M; Gutiérrez NG; Lam-Franco L; Tamargo-Barrera D; Martínez U; Bustamante-Careaga H; Alvarez MM; Schultz-Cherry S
    Respir Care; 2012 Oct; 57(10):1586-93. PubMed ID: 22418453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.
    Waalen K; Kilander A; Dudman SG; Krogh GH; Aune T; Hungnes O
    Euro Surveill; 2010 Aug; 15(31):. PubMed ID: 20738992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serologic survey on pandemic influenza A (H1N1) virus among aged ≥ 3 years population from Jiangsu province in 2009, China].
    Tang FY; Zu RQ; Li L; Qi X; Ji H; Wu B; Xu K; Fu JG; Qin YF; Deng F; Yang HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):489-93. PubMed ID: 21163021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y; Pang XH; Yang P; Shi WX; Tian LL; Liu BW; Li S; Cui SJ; Li Y; Lu GL; Zhang L; Zhang X; Liu B; Seale H; Huang F; Wang QY
    Epidemiol Infect; 2011 Jan; 139(1):52-8. PubMed ID: 20854713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.
    Kumar S; Fan J; Melzer-Lange M; Trost J; Havens PL; Willoughby RE; Chusid MJ; Henrickson KJ
    Pediatr Emerg Care; 2011 Sep; 27(9):804-7. PubMed ID: 21878831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A survey on serological epidemiology of influenza A (H1N1) 2009 in Beijing].
    Yang P; Huang F; Shi WX; Lu GL; Tian LL; Cui SJ; Zhang X; Li S; Liu BW; Deng Y; Pang XH; Wang QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):485-8. PubMed ID: 21163020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.